PRESS RELEASE published on 01/23/2024 at 17:00, 1 year 10 months ago Introducing Smilefy 4.0 — Revolutionizing Dental Aesthetics With Automated 3D Smile Design Powered by AI Smilefy Inc. has announced the release of Smilefy 4.0, a cutting-edge 3D Smile Design powered by AI that is set to revolutionize cosmetic and restorative dentistry. This innovative solution enables dental professionals to create 3D Smile Designs in minutes and generate 3D print-ready mockups, shells, composite veneers, and temps models chairside, offering higher efficiency, cost savings, and a better patient experience. Integrating AI into daily dental operations, Smilefy 4.0 embodies this shift, enhancing workflow efficiency and yielding considerable time and cost savings for dental practices. With Smilefy AI automating the process of 3D smile design, the solution offers precision, adaptability, and a user-friendly platform, enhancing practice efficiency, treatment outcome accuracy, and patient satisfaction worldwide. AI Technology Smilefy 4.0 3D Smile Design Dental Aesthetics Digital Dental Solutions
Published on 12/18/2025 at 00:55, 3 hours 12 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 4 hours 7 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 52 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 13 hours 7 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 14 hours 7 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/18/2025 at 01:10, 2 hours 57 minutes ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 17 minutes ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 6 hours 2 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 6 hours 2 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 45 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 7 hours 28 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 28 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 37 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 10 hours 7 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025